CRISPR Used for the First Time to Treat a Blind Patient

Until now the CRISPR system, also known as “genetic scissors”, was only tested in the laboratory. Now for the first time, CRISPR has been used on a man with an inherited form of blindness.


“We literally have the potential to take people who are essentially blind and make them see,” Charles Albright, chief scientific officer of Editas Medicine, told the AP.

Read Also: First CRISPR Trials on Humans Are Now Being Implemented in the US

This is not a miracle but could become a reality if all goes as planned. A team from Oregon Health & Science Institute has used the CRISPR system to treat a patient with an inherited form of blindness – Leber congenital amaurosis- caused by a genetic mutation that prevents the production of a protein needed to convert light into signals for the brain.

Read Also: New Therapy Restores Vision Loss by Calming down Hyperactive Eye Cells

This disease cannot be treated with standard gene therapy, where a replacement gene is provided because it is too large to be incorporated into incapacitated viruses, the classical route for the transport of new genes into cells.

Suppression of the mutation responsible for the disease

“As a result the doctors decided to treat this patient with CRISPR to remove the mutation responsible for the disease, making two incisions on each side of the gene in the hope that the ends of the DNA would reconnect and the gene could function normally,” explains the Associated Press.

Related: UC Berkeley Researchers Restore Vision in Mice Through Gene Insertion

The surgical technique of the CRISPR system, in this case, was quite simple: under general anesthesia, three drops of a liquid containing the CRISPR system were administered to the patient through a hair-sized tube directly under the retina at the back of the eye where the light-sensitive cells are located.

The risk of unintentional changes in other genes

The scientists gave themselves one month after the intervention to ensure that this process was really able to restore sight. However, all previous animal tests showed that this treatment could correct the cell’s defective genetic code.

Read Also: An Artificial Retina to Restore Sight Could Soon Become a Reality

Although the CRISPR system represents a great hope for gene therapy, there is a risk that using the system to process one gene may cause involuntary changes in other genes with unknown and not necessarily controllable consequences. Therefore, this “first” in the field of medicine is closely followed by the scientific community.


Related Articles:

Doctors Investigate CRISPR Gene-Editing for Treatment of Sickle Cell Disease

Herpes Could Finally Be Cured With CRISPR According to Study

CRISPR Prevents Liver Disease In Mice Before Birth

Study Shows That CRISPR-Edited T Cells for Cancer Treatment Are Safe and Long-Lasting

Age-related Close-up Vision Loss- How do I rid myself of reading glasses?



Want to Stay Informed?

Join the Gilmore Health News Newsletter!

Want to live your best life?

Get the Gilmore Health Weekly newsletter for health tips, wellness updates and more.

By clicking "Subscribe," I agree to the Gilmore Health and . I also agree to receive emails from Gilmore Health and I understand that I may opt out of Gilmore Health subscriptions at any time.